Menu

Mead Johnson Nutrition Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance

GLENVIEW, Ill.--(BUSINESS WIRE)--Jan. 26, 2017-- Mead Johnson Nutrition Company (NYSE: MJN) today announced its financial results for the quarter and year ended December 31, 2016.

Highlights are as follows:

"In the fourth quarter we continued to make progress with a series of important strategic transitions in key markets. Our imported products again grew strongly in China - and we doubled our sales volume via e-commerce out of Hong Kong over the prior quarter. Though it will take some time for us to complete the transition phase we are currently in, we are encouraged by early signs our plans are working," said Kasper Jakobsen, Chief Executive Officer.

(1) Constant dollar figures exclude the impact of changes in foreign currency exchange rates and are reconciled in the tables in the body of this earnings release and in the schedules titled “Reconciliation of non-GAAP to GAAP Results.” Non-GAAP results exclude Specified Items. For a description of Specified Items and a reconciliation of non-GAAP to GAAP, see the schedules titled “Reconciliation of non-GAAP to GAAP Results.”

 
Fourth Quarter 2016
(Dollars in Millions)
(UNAUDITED)
 
    Three Months Ended December 31,     % Change     % Change Due to
  % of     % of   Constant     Foreign
Net Sales 2016 Total 2015 Total Reported Dollar Volume Price/Mix Exchange
Asia $436.9 48% $468.0 48% (7)% (4)% (5)% 1% (3)%
Latin America 156.3 17% 169.8 18% (8)% 4% (6)% 10% (12)%
North America/Europe 308.4 35% 329.2 34% (6)% (5)% (8)% 3% (1)%
Net Sales $901.6 100% $967.0 100% (7)% (3)% (6)% 3% (4)%
 
         
% Change
Three Months Ended December 31, % Change Due to
  % of     % of   Constant Foreign
Earnings Before Interest and Income Taxes (EBIT) 2016 Sales 2015 Sales Reported Dollar Exchange
Asia $118.6 27% $139.9 30% (15)% (7)% (8)%
Latin America 39.6 25% 34.2 20% 16% 33% (17)%
North America/Europe 92.0 30% 96.9 29% (5)% (1)% (4)%
Corporate and Other (a) (24.2) (75.2) 68%
GAAP EBIT 226.0 25% 195.8 20% 15% 25% (10)%
Non-GAAP EBIT $208.1 $219.6 (5)% 4% (9)%
 

(a) All Specified Items are included in Corporate and Other.

 
 
Full Year 2016
(Dollars in Millions)
(UNAUDITED)
 
    Year Ended December 31,     % Change     % Change Due to
  % of     % of   Constant     Foreign
Net Sales 2016 Total 2015 Total Reported Dollar Volume Price/Mix Exchange
Asia $ 1,856.9 50% $ 2,039.0 50% (9)% (5)% (6)% 1% (4)%
Latin America 643.7 17% 757.1 19% (15)% (1)% (10)% 9% (14)%
North America/Europe 1,242.1   33% 1,275.2   31% (3)% (2)% (4)% 2% (1)%
Net Sales $ 3,742.7   100% $ 4,071.3   100% (8)% (3)% (6)% 3% (5)%
 
            % Change
Year Ended December 31, % Change Due to
  % of     % of   Constant Foreign
Earnings Before Interest and Income Taxes (EBIT) 2016 Sales 2015 Sales Reported Dollar Exchange
Asia $559.3 30% $682.0 33% (18)% (12)% (6)%
Latin America 156.7 24% 175.2 23% (11)% 10% (21)%
North America/Europe 380.3 31% 361.8 28% 5% 9% (4)%
Corporate and Other (a) (277.6) (282.8) 2%
GAAP EBIT 818.7 22% 936.2 23% (13)% (4)% (9)%
Non-GAAP EBIT $926.8 $980.8 (6)% 3% (9)%
 

(a) All Specified Items are included in Corporate and Other.

 

Cash Flow Items and Liquidity

Outlook

For 2017, the company expects full year net sales to be in the range of -3% to 0% compared to 2016 on a reported basis, and in the range of -1% to +2% compared to 2016 on a constant dollar basis. Based upon recent spot rates, the estimated adverse foreign exchange impact is approximately 2%. Sales on a reported basis will be impacted by future foreign exchange changes which cannot be estimated.

The company expects 2017 GAAP EPS to be in the range of $3.05 to $3.20. GAAP EPS guidance includes estimated adverse foreign exchange impacts of approximately $0.20, based on recent spot rates. GAAP EPS will be impacted by future foreign exchange changes and potentially significant future specified mark-to-market pension adjustments which cannot be estimated. Specified Items such as charges related to Fuel for Growth and other items are estimated to be $0.10 in 2017. The company expects non-GAAP EPS of $3.35 to $3.50 on a constant dollar basis.

Kasper Jakobsen continued, "2017 will see us complete our strategic transition program. We expect some pressure on both topline and costs in the beginning of the year, and the impact of currency and rising dairy costs will likely weigh on results. The impact will be partially offset by momentum behind productivity initiatives in both cost of goods and operating expenses. As previously stated, we expect only very modest growth in both Sales and EPS on a constant dollar basis - with performance strengthening through the second half of the year."

Conference Call Scheduled

Mead Johnson will host a conference call at 8:30 a.m. U.S. Central Time, during which company executives will review the financial results for the fourth quarter and full year 2016. The call will be broadcast with accompanying slides over the Internet at http://investors.meadjohnson.com. Security analysts and investors wishing to participate by telephone should call 877-359-9508, pass code: Mead Johnson. Callers outside of North America should call +1-224-357-2393 to be connected. A replay of the conference call will be available through 11:00 p.m. U.S. Central Time Sunday, March 12, 2017, by calling 855-859-2056, or outside of North America by calling +1-404-537-3406, passcode: 37021489. The replay will also be available at meadjohnson.com.

Forward-Looking Statements

Certain statements in this news release are forward-looking as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the fact they use words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression. Such statements are likely to relate to, among other things, a discussion of goals, plans and projections regarding financial position, results of operations, cash flows, market position, product development, product approvals, sales efforts, expenses, capital expenditures, performance or results of current and anticipated products and the outcome of contingencies such as legal proceedings and financial results. Forward-looking statements can also be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements are based on current expectations that involve inherent risks, uncertainties and assumptions that may cause actual results to differ materially from expectations as of the date of this news release. These risks include, but are not limited to: (1) the ability to sustain brand strength, particularly the Enfa family of brands; (2) the effect on the company’s reputation of real or perceived quality issues; (3) the effect of regulatory restrictions related to the company’s products; (4) the adverse effect of commodity costs; (5) increased competition from branded, private label, store and economy-branded products; (6) the effect of an economic downturn on consumers’ purchasing behavior and customers’ ability to pay for product; (7) inventory reductions by customers; (8) the adverse effect of changes in foreign currency exchange rates; (9) the effect of changes in economic, political and social conditions in the markets where we operate; (10) changing consumer preferences; (11) the possibility of changes in the WIC program, or participation in WIC(2); (12) legislative, regulatory or judicial action that may adversely affect the company’s ability to advertise its products, maintain product margins, or negatively impact the company’s reputation or result in fines or penalties that decrease earnings; and (13) the ability to develop and market new, innovative products. For additional information regarding these and other factors, see the company’s filings with the United States Securities and Exchange Commission (the “SEC”), including its most recent Annual Report on Form 10-K, which filings are available upon request from the SEC or at www.meadjohnson.com. The company cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company’s mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s “Enfa” family of brands, including Enfamil® infant formula, is the world’s leading brand franchise in pediatric nutrition. For more information, go to www.meadjohnson.com.

(2) The Special Supplemental Nutrition Program for Women, Infants and Children (WIC) is a federal assistance program of the Food and Nutrition Services (FNS) of the United States Department of Agriculture (USDA).

 
MEAD JOHNSON NUTRITION COMPANY
CONSOLIDATED STATEMENTS OF EARNINGS
(Dollars and shares in millions, except per share data)
(UNAUDITED)
 
    Three Months Ended December 31,     Year Ended December 31,
2016   2015 2016   2015
NET SALES $ 901.6 $ 967.0 $ 3,742.7 $ 4,071.3
Cost of Products Sold 326.5   358.6   1,341.0   1,455.3
GROSS PROFIT 575.1 608.4 2,401.7 2,616.0
Operating Expenses:
Selling, General and Administrative 170.9 211.1 766.5 890.6
Advertising and Promotion 146.9 151.1 627.0 641.8
Research and Development 22.5 28.5 97.4 108.4
Other (Income)/Expenses – net 8.8   21.9   92.1   39.0
EARNINGS BEFORE INTEREST AND INCOME TAXES 226.0 195.8 818.7 936.2
 
Interest Expense – net 26.5   22.5   105.4   65.0
EARNINGS BEFORE INCOME TAXES 199.5 173.3 713.3 871.2
 
Provision for Income Taxes 31.3   42.3   164.0   215.9
NET EARNINGS 168.2 131.0 549.3 655.3
Less: Net Earnings Attributable to Noncontrolling Interests 0.4   3.0   4.4   1.8
NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS $ 167.8   $ 128.0   $ 544.9   $ 653.5
 
Earnings per Share – Basic
Net Earnings Attributable to Shareholders $ 0.91   $ 0.67   $ 2.93   $ 3.28
Earnings per Share – Diluted
Net Earnings Attributable to Shareholders $ 0.91   $ 0.67   $ 2.92   $ 3.27
 
Weighted-average Shares - Diluted 184.4 189.8 185.8 199.4
Dividends Declared per Share $ 0.4125 $ 0.4125 $ 1.6500 $ 1.6500

(a) The numerator for basic and diluted earnings per share is net earnings attributable to shareholders. Net earnings has been reduced by dividends and undistributed earnings attributable to unvested share based incentive plan awards. The denominator for basic earnings per share is the weighted-average shares outstanding during the period. The denominator for diluted earnings per share is the weighted-average shares outstanding adjusted for the effect of dilutive stock options and performance share awards.

 
MEAD JOHNSON NUTRITION COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars and shares in millions, except per share data)
(UNAUDITED)
 
    December 31, 2016     December 31, 2015
ASSETS
CURRENT ASSETS:
Cash and Cash Equivalents $ 1,795.4 $ 1,701.4
Receivables—net of allowances of $4.4 and $5.4, respectively 369.0 342.5
Inventories 473.5 484.9
Income Taxes Receivable 8.3 13.2
Prepaid Expenses and Other Assets 60.4   60.4  
Total Current Assets 2,706.6 2,602.4
Property, Plant and Equipment—net 948.6 964.0
Goodwill 108.9 126.0
Other Intangible Assets—net 46.0 54.9
Deferred Income Taxes—net of valuation allowance 143.1 118.5
Other Assets 134.5   132.3  
TOTAL $ 4,087.7   $ 3,998.1  
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Short-term Borrowings $ 3.9 $ 3.0
Accounts Payable 515.8 481.5
Dividends Payable 76.0 77.8
Accrued Expenses 194.7 213.0
Accrued Rebates and Returns 417.4 376.8
Deferred Income 12.4 35.5
Income Taxes Payable 24.0   65.7  
Total Current Liabilities 1,244.2 1,253.3
Long-Term Debt 2,976.2 2,981.0
Deferred Income Taxes 6.2 8.7
Pension and Other Post employment Liabilities 104.2 132.4
Other Liabilities 229.0   215.2  
Total Liabilities 4,559.8 4,590.6
COMMITMENTS AND CONTINGENCIES
 
EQUITY
Shareholders’ Equity
Common Stock, $0.01 par value: 3,000 authorized, 188.3 and 191.4 issued, respectively 1.9 1.9
Additional Paid-in/(Distributed) Capital (514.0 ) (564.2 )
Retained Earnings 873.8 640.4
Treasury Stock—at cost (463.0 ) (362.6 )
Accumulated Other Comprehensive Income/(Loss) (411.4 ) (347.8 )
Total Shareholders’ Equity/(Deficit) (512.7 ) (632.3 )
Noncontrolling Interests 40.6   39.8  
Total Equity/(Deficit) (472.1 ) (592.5 )
TOTAL $ 4,087.7   $ 3,998.1  
 
MEAD JOHNSON NUTRITION COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in millions)
(UNAUDITED)
 
    Year Ended December 31,
2016     2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Earnings $ 549.3 $ 655.3
Adjustments to Reconcile Net Earnings to Net Cash Provided by Operating Activities:
Depreciation and Amortization 99.6 99.1
Stock-Based Compensation Expense 34.6 26.4
Deferred Income Taxes (53.3 ) 43.3
Exchange Loss from Devaluation 31.7 2.3
Mark-to-market on Trading Security (5.6 )
Pension and Other Post-employment Benefits Expense (7.4 ) 12.8
Impairment of Long-Lived Assets 45.9
Other (3.6 ) (1.4 )
Change in Assets and Liabilities:
Receivables (42.0 ) 10.4
Inventories (8.9 ) 25.8
Accounts Payable 52.5 3.7
Accrued Expenses, Rebates and Returns 47.0 73.8
Income Taxes Payable (40.7 ) 15.3
Other Assets and Liabilities 6.2 38.8
Pension and Other Post-employment Benefits Contributions (19.3 ) (90.1 )
Net Cash Provided by Operating Activities 691.6 909.9
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments for Capital Expenditures (149.0 ) (173.7 )
Proceeds from Sale of Property, Plant and Equipment 0.3   0.5  
Net Cash Used in Investing Activities (148.7 ) (173.2 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Short-term Borrowings 1.6 1,003.0
Repayments of Short-term Borrowings (0.3 ) (1,002.9 )
Proceeds from Issuance of Long-term Notes, net of original issue discounts and expenses paid (0.1 ) 1,487.7
Proceeds from Long-term Revolver Borrowings 446.0
Repayment of Long-term Revolver Borrowings (446.0 )
Payments of Dividends (308.8 ) (326.0 )
Stock-based Compensation related Proceeds and Excess Tax Benefits 15.9 25.4
Stock-based Compensation Tax Withholdings (4.4 ) (11.4 )
Payments for Repurchase of Common Stock (100.4 ) (1,437.0 )
Purchase of Noncontrolling Interest Redeemable Shares (24.2 )
Purchase of Trading Securities (16.2 )
Sale of Trading Securities 21.7
Distributions to Noncontrolling Interests (3.1 ) (6.9 )
Net Cash Used in Financing Activities (399.6 ) (286.8 )
Effects of Changes in Exchange Rates on Cash and Cash Equivalents (49.3 ) (46.2 )
NET INCREASE IN CASH AND CASH EQUIVALENTS 94.0 403.7
CASH AND CASH EQUIVALENTS:
Beginning of Period 1,701.4   1,297.7  
End of Period $ 1,795.4   $ 1,701.4  
 

Mead Johnson Nutrition Company
Financial Information (UNAUDITED)
Reconciliation of Non-GAAP to GAAP Results

This news release contains non-GAAP financial measures, each of which is listed in the tables below. The items included in GAAP measures, but excluded for the purpose of determining the non-GAAP financial measures, include significant income/expenses not indicative of underlying operating results, including the related tax effect and, at times, the impact of foreign exchange. The non-GAAP measures represent an indication of the company’s underlying operating results and are intended to enhance an investor’s overall understanding of the company’s financial performance and ability to compare the company’s performance to that of its peer companies. In addition, this information is among the primary indicators the company uses as a basis for evaluating company performance, setting incentive compensation targets and planning and forecasting of future periods. This information is not intended to be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. Tables that reconcile non-GAAP to GAAP disclosure follow below.

Constant Dollar

Certain measures in this release are presented excluding the impact of foreign currency exchange (constant dollar). To present this information, current period results for entities reporting in currencies other than United States dollars are translated into United States dollars at the average exchange rates in effect during the corresponding period of the prior fiscal year, rather than the actual average exchange rates in effect during the current fiscal year. The company believes that these constant dollar measures provide useful information to investors because they provide transparency to underlying performance by excluding the effect that foreign currency exchange rate fluctuations have on period-to-period comparability given volatility in foreign currency exchange markets. The primary currencies which impact the company are: the Argentine peso, the Chinese renminbi, the Hong Kong dollar, the Mexican peso and the Philippine peso.

Specified Items

Non-GAAP measures presented within this release exclude Specified Items. The company considers Specified Items to be significant income/expense items as not indicative of underlying operating results, including the related tax effect. See below for a description of Specified Items and the related tax effect.

Mead Johnson Nutrition Company
Financial Information (UNAUDITED)
Reconciliation of Non-GAAP to GAAP Results
 

Constant dollar gross sales

 
        Three Months Ended December 31,         % Change
        Foreign       Constant
Gross Sales 2016 2015 Reported Exchange Dollar
Total gross sales $ 1,265.3 $ 1,310.2 (3)% (3)% —%
 

Constant dollar net sales

 
    Three Months Ended    
December 31, % Change
                    Constant
Dollar
Foreign Constant Impact of Excluding
Net Sales 2016 2015 Reported Exchange Dollar Venezuela Venezuela
Asia $ 436.9 $ 468.0 (7)% (3)% (4)%
Latin America 156.3 169.8 (8)% (12)% 4% (4)% 8%
North America/Europe 308.4   329.2   (6)% (1)% (5)%
Net Sales 901.6 $ 967.0 (7)% (4)% (3)% (1)% (2)%
Impact of Foreign Exchange 37.3  
Constant Dollar Sales $ 938.9
 
    Year Ended December 31,     % Change
                    Constant
Dollar
Foreign Constant Impact of Excluding
Net Sales 2016 2015 Reported Exchange Dollar Venezuela Venezuela
Asia $ 1,856.9 $ 2,039.0 (9)% (4)% (5)%
Latin America 643.7 757.1 (15)% (14)% (1)% (7)% 6%
North America/Europe 1,242.1   1,275.2   (3)% (1)% (2)%
Net Sales 3,742.7 $ 4,071.3 (8)% (5)% (3)% (1)% (2)%
Impact of Foreign Exchange 189.7  
Constant Dollar Sales $ 3,932.4
 

Non-GAAP constant dollar gross margin

 
    Three Months Ended December 31,     Year Ended December 31,
2016   2015     2016   2015    
Gross   Gross Gross   Gross Gross   Gross Gross   Gross
Profit Margin Profit Margin Change Profit Margin Profit Margin Change
GAAP Gross Profit and Gross Margin $ 575.1 63.8 % $ 608.4 62.9 % 0.9% $ 2,401.7 64.2 % $ 2,616.0 64.3 % (0.1)%
Pension Remeasurement (a) (10.5 ) (1.2 )% (0.4 ) (0.1 )% (2.5 ) (0.1 )% 3.0 0.1 %
Fuel for Growth (b) —% 10.3 1.0 % —% 10.3 0.2 %
Foreign currency impact 36.6   1.4 %   170.1   1.2 %  
Non-GAAP Constant Dollar Gross Profit and Gross Margin $ 601.2 64.0 % $ 618.3 63.9 % 0.1% $ 2,569.3 65.3 % $ 2,629.3 64.6 % 0.7%
 

Non-GAAP constant dollar selling, general and administrative expenses

 
    Three Months Ended December 31,     Year Ended December 31,
2016   2015   % Change 2016   2015   % Change
GAAP SG&A $ 170.9 $ 211.1 (19 )% $ 766.5 $ 890.6 (14 )%
Pension Remeasurement (a) 17.3 1.1 4.2 (4.4 )
Venezuela (d) (2.0 )
Fuel for Growth (b) (0.4 ) (0.4 )
All Other (e) (0.8 ) (0.1 ) (2.4 ) (2.0 )
Foreign currency impact 11.0     40.2    
Non-GAAP Constant Dollar SG&A $ 198.4 $ 211.7 (6 )% $ 806.5 $ 883.8 (9 )%
 

Constant dollar segment EBIT

 
    Three Months Ended December 31,     % Change
        Foreign       Constant
Earnings Before Interest and Income Taxes (EBIT) 2016 2015 Reported Exchange Dollar
Asia $ 118.6 $ 139.9 (15)% (8)% (7)%
Latin America 39.6 34.2 16% (17)% 33%
North America/Europe 92.0 96.9 (5)% (4)% (1)%
 
    Year Ended December 31,     % Change
    Foreign   Constant
Earnings Before Interest and Income Taxes (EBIT) 2016 2015 Reported Exchange Dollar
Asia $ 559.3 $ 682.0 (18)% (6)% (12)%
Latin America 156.7 175.2 (11)% (21)% 10%
North America/Europe 380.3 361.8 5% (4)%

9%

 

Non-GAAP Corporate and Other EBIT

 
    Three Months Ended December 31,    
Corporate and Other 2016   2015 % Change
EBIT $ (24.2 ) $ (75.2 ) 68%
Pension Remeasurement (a) (30.8 ) (1.7 )
Fuel for Growth (b) 10.8 25.1
Venezuela (d) 0.6
All Other (e) 1.5   0.4  
Non-GAAP EBIT $ (42.1 ) $ (51.4 ) 18%
 
    Year Ended December 31,        
Corporate and Other 2016       2015 % Change
EBIT $ (277.6 ) $ (282.8 ) 2%
Pension Remeasurement (a) (7.4 ) 8.2
Investigation Accrual (c) 12.0
Fuel for Growth (b) 29.2 25.1
Venezuela (d) 81.8
All Other (e) 4.5   (0.7 )
Non-GAAP EBIT $ (169.5 ) $ (238.2 ) 29%
 

Non-GAAP EBIT and constant dollar EBIT

 
    Three Months Ended December 31,     % Change
        Constant   Foreign
2016 2015 Reported   Dollar   Exchange
EBIT $ 226.0 $ 195.8 15 % 25 % (10 )%
Pension Remeasurement (a) (30.8 ) (1.7 )
Investigation Accrual (c)
Fuel for Growth (b) 10.8 25.1
Venezuela (d) 0.6
All Other (e) 1.5   0.4  
Non-GAAP EBIT 208.1 219.6 (5 )%
Foreign currency impact 19.3    
Non-GAAP Constant Dollar EBIT $ 227.4 $ 219.6 4 %
 
    Year Ended December 31,     % Change
        Constant   Foreign
2016 2015 Reported   Dollar   Exchange
EBIT $ 818.7 $ 936.2 (13 )% (4

)%

(9

)%

Pension Remeasurement (a) (7.4 ) 8.2
Investigation Accrual (c) 12.0
Fuel for Growth (b) 29.2 25.1
Venezuela (d) 81.8
All Other (e) 4.5   (0.7 )
Non-GAAP EBIT 926.8 980.8 (6 )%
Foreign currency impact 80.2    
Non-GAAP Constant Dollar EBIT $ 1,007.0 $ 980.8 3 %
 

Non-GAAP diluted EPS

 
    Three Months Ended December 31,     Year Ended December 31,
2016   2015   % Change 2016   2015   % Change
GAAP EPS-Diluted $ 0.91 $ 0.67 36 % $ 2.92 $ 3.27 (11 )%
Pension Remeasurement (a) (0.11 ) (0.01 ) (0.03 ) 0.03
Investigation Accrual (c) 0.04
Fuel for Growth (b) 0.05 0.11 0.13 0.11
Venezuela (d) (0.08 ) 0.36
All Other (e)     0.02   (0.01 )
Non-GAAP EPS * $ 0.78 $ 0.78

%

$ 3.40 $ 3.44 (1 )%

* Figures may not sum due to rounding.

 

Consolidated Net Debt

 
    December 31, 2016     December 31, 2015
Short-term borrowings $ 3.9 $ 3.0
Long-Term Debt 2,976.2 2,981.0
Total Debt 2,980.1 2,984.0
Less: Cash and cash equivalents 1,795.4 1,701.4
Net debt $ 1,184.7 $ 1,282.6
 

Non-GAAP Guidance

 
    High End     Low End
Reported Sales % (3 )%
Less impact of Foreign Currency (2 )% (2 )%
Constant Dollar Sales 2 % (1 )%
 
GAAP Earnings per Share $ 3.20 $ 3.05
Less Specified Items (0.10 ) (0.10 )
Less impact of Foreign Currency (0.20 ) (0.20 )
Non-GAAP Earnings per Share $ 3.50 $ 3.35
 

(a) Pension Remeasurement: When incurred, gains and losses related to the remeasurement of defined benefit pension and post-employment benefit plans are classified as Specified Items and excluded from non-GAAP performance measures. Pension remeasurement reflects changes in the pension assets and liabilities above what was estimated and included in periodic costs. Factors beyond our control such as changes in discount rates, market volatility and mortality assumptions drive the remeasurement amount. The majority of our pension and post-employment plans are frozen, and therefore the benefit provided to such employees is not related to our underlying operations.

(b) Fuel for Growth: The Company approved a plan to implement a business productivity program referred to as “Fuel for Growth,” during the third quarter of 2015, which is anticipated to be implemented over a three-year period. Fuel for Growth is designed to improve operating efficiencies and reduce costs. Fuel for Growth is expected to improve profitability and create additional investments behind brand building and growth initiatives. Fuel for Growth focuses on the optimization of resources within various operating functions and certain third party costs across the business.

(c) Investigation Accrual: An accrual made in connection with the SEC settlement disclosed by the company in July 2015.

(d) Venezuela: Foreign exchange losses, long-lived asset impairments and other asset write-offs in Venezuela.

(e) All Other: Primarily includes restructuring costs in 2016 and a marketable securities gain in 2015.

Source: Mead Johnson Nutrition Company

Mead Johnson Nutrition:
Investors:
Kathy MacDonald, 847-832-2182
kathy.macdonald@mjn.com
or
Media:
Christopher Perille, 847-832-2178
chris.perille@mjn.com

1/26/2017